BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 9519009)

  • 1. Amiodarone and mortality in CHF and post-MI.
    Zamorski M
    J Fam Pract; 1998 Mar; 46(3):196-7. PubMed ID: 9519009
    [No Abstract]   [Full Text] [Related]  

  • 2. Effect of prophylactic amiodarone on mortality after acute myocardial infarction and in congestive heart failure: meta-analysis of individual data from 6500 patients in randomised trials. Amiodarone Trials Meta-Analysis Investigators.
    Lancet; 1997 Nov; 350(9089):1417-24. PubMed ID: 9371164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amiodarone in high-risk post-infarction patients, Lessons from EMIAT and CAMIAT. European Myocardial Infarct Amiodarone Trial and Canadian Amiodarone Myocardial Infarction Arrhythmia Trial.
    Gambhir DS
    Indian Heart J; 1996; 48(4):339-41. PubMed ID: 8908817
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mishaps with anti-arrhythmic agents used to reduce mortality after infarction].
    Funck-Brentano C
    Rev Prat; 1992 Nov; 42(17):2175-8. PubMed ID: 1290040
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amiodarone: a late comer.
    Futterman LG; Lemberg L
    Am J Crit Care; 1997 May; 6(3):233-9. PubMed ID: 9131203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
    Gronda E; Mangiavacchi M; Andreuzzi B; Municinò A
    Ital Heart J Suppl; 2001 Dec; 2(12):1278-83. PubMed ID: 11838348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Death is still a death. Does it matter if the cause is myocardial infarction or arrhythmia?].
    Werkö L
    Lakartidningen; 1998 Jan; 95(4):246-8. PubMed ID: 9469947
    [No Abstract]   [Full Text] [Related]  

  • 8. The prophylactic use of anti-arrhythmic drugs in acute myocardial infarction.
    Chung EK
    Singapore Med J; 1973 Sep; 14(3):205-10. PubMed ID: 4591400
    [No Abstract]   [Full Text] [Related]  

  • 9. Antiarrhythmic trials: a decade of growth.
    Kanjwal MY
    Indian Heart J; 1998; 50(3):277-84. PubMed ID: 9753848
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter to the neurology editor.
    Vajda FJ
    J Clin Neurosci; 2005 Feb; 12(2):210. PubMed ID: 15749437
    [No Abstract]   [Full Text] [Related]  

  • 11. Antiarrhythmic therapy in the post-infarction setting: update from major amiodarone studies.
    Cairns JA
    Int J Clin Pract; 1998 Sep; 52(6):422-4. PubMed ID: 9894381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of arrhythmias after myocardial infarction in the post-CAST era.
    Camm AJ; Kautzner J
    Can J Cardiol; 1996 Apr; 12 Suppl B():9B-19B; discussion 27B-28B. PubMed ID: 8616727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-effectiveness of tests to assess the risk of sudden death after acute myocardial infarction.
    Hlatky MA; Owens DK
    J Am Coll Cardiol; 1998 Jun; 31(7):1490-2. PubMed ID: 9626824
    [No Abstract]   [Full Text] [Related]  

  • 14. Depressed heart rate variability identifies postinfarction patients who might benefit from prophylactic treatment with amiodarone: a substudy of EMIAT (The European Myocardial Infarct Amiodarone Trial).
    Malik M; Camm AJ; Janse MJ; Julian DG; Frangin GA; Schwartz PJ
    J Am Coll Cardiol; 2000 Apr; 35(5):1263-75. PubMed ID: 10758969
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amiodarone after myocardial infarction: EMIAT and CAMIAT trials.
    Malik M; Camm AJ
    Lancet; 1997 Jun; 349(9067):1767-8. PubMed ID: 9193398
    [No Abstract]   [Full Text] [Related]  

  • 16. Role of antiarrhythmic agents after myocardial infarction with special reference to the EMIAT and CAMIAT trials of amiodarone. European Myocardial Infarct Amiodarone Trial. Canadian Amiodarone Myocardial Infarction Trial.
    Jafri SM; Borzak S; Goldberger J; Gheorghiade M
    Prog Cardiovasc Dis; 1998; 41(1):65-70. PubMed ID: 9717860
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicenter clinical trial on the prevention of sudden death after myocardial infarction by the use of anti-arrhythmia agents. Investigator Group of the Spanish Study on Sudden Death].
    Rev Esp Cardiol; 1989 Feb; 42(2):77-83. PubMed ID: 2675221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiac Arrhythmia Suppression Trial: a disappointment?].
    Magalhães CO
    Arq Bras Cardiol; 1990 Sep; 55(3):153-4. PubMed ID: 2095719
    [No Abstract]   [Full Text] [Related]  

  • 19. The current role of amiodarone in patients with congestive heart failure.
    Bello D; Massie BM
    Cleve Clin J Med; 1998 Oct; 65(9):479-89. PubMed ID: 9795489
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical efficacy of amiodarone.
    Nolan PE; Nappi J; Pollak PT
    Pharmacotherapy; 1998; 18(6 Pt 2):127S-137S. PubMed ID: 9855345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.